Literature DB >> 8682208

Molecular mechanisms in the disassembly and reassembly of the mammalian Golgi apparatus during M-phase.

T Misteli1.   

Abstract

The mitotic disassembly and reassembly of the mammalian Golgi apparatus is an ideal system to study the molecular mechanisms involved in biogenesis and maintenance of membranous organelles. As cells enter M-phase, Golgi stacks are converted into Golgi clusters of small membrane fragments, which are dispersed throughout the cytoplasmic space during metaphase. Disassembly is dependent on the action of cdc2-kinase and at least two distinct pathways contribute to the fragmentation: one involves the budding of COP I-coated vesicles from Golgi cisternae, the other is a less well characterised COP I-independent pathway. During telophase, the Golgi fragments reassemble and fuse into a fully functional Golgi stack, using at least two distinct ATPase-mediated fusion pathways.

Entities:  

Mesh:

Year:  1996        PMID: 8682208     DOI: 10.1016/0014-5793(96)00518-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

Review 1.  Sorting and storage during secretory granule biogenesis: looking backward and looking forward.

Authors:  P Arvan; D Castle
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

2.  Golgi apparatus self-organizes into the characteristic shape via postmitotic reassembly dynamics.

Authors:  Masashi Tachikawa; Atsushi Mochizuki
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

3.  Clathrin is required for postmitotic Golgi reassembly.

Authors:  Andreea E Radulescu; Dennis Shields
Journal:  FASEB J       Date:  2011-09-29       Impact factor: 5.191

4.  COG-7-deficient Human Fibroblasts Exhibit Altered Recycling of Golgi Proteins.

Authors:  Richard Steet; Stuart Kornfeld
Journal:  Mol Biol Cell       Date:  2006-03-01       Impact factor: 4.138

5.  Protein-Protein Interactions Suggest Novel Activities of Human Cytomegalovirus Tegument Protein pUL103.

Authors:  Daniel A Ortiz; James E Glassbrook; Philip E Pellett
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.